: An amendment to this paper has been published and can be accessed via the original article.

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study) (vol 20, 191, 2019) / Femminella, G.D., Frangou, E., Love, S.B., Busza, G., Holmes, C., Ritchie, C., Lawrence, R., Mcfarlane, B., Tadros, G., Ridha, B.H., Bannister, C., Walker, Z., Archer, H., Coulthard, E., Underwood, B.R., Prasanna, A., Koranteng, P., Karim, S., Junaid, K., Mcguinness, B., et al.. - In: TRIALS. - ISSN 1745-6215. - 21:1(2020), p. 660. [10.1186/S13063-020-04608-4]

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study) (vol 20, 191, 2019)

Femminella, Grazia Daniela;
2020

Abstract

: An amendment to this paper has been published and can be accessed via the original article.
2020
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study) (vol 20, 191, 2019) / Femminella, G.D., Frangou, E., Love, S.B., Busza, G., Holmes, C., Ritchie, C., Lawrence, R., Mcfarlane, B., Tadros, G., Ridha, B.H., Bannister, C., Walker, Z., Archer, H., Coulthard, E., Underwood, B.R., Prasanna, A., Koranteng, P., Karim, S., Junaid, K., Mcguinness, B., et al.. - In: TRIALS. - ISSN 1745-6215. - 21:1(2020), p. 660. [10.1186/S13063-020-04608-4]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/944484
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 11
  • ???jsp.display-item.citation.isi??? ND
social impact